Embla Medical hf.
OSSFF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,701,942 | $1,672,880 | $1,771,740 | $1,675,872 |
| - Cash | $102,055 | $94,072 | $91,770 | $86,163 |
| + Debt | $562,335 | $565,426 | $528,547 | $499,789 |
| Enterprise Value | $2,162,222 | $2,144,235 | $2,208,517 | $2,089,498 |
| Revenue | $236,118 | $236,138 | $202,786 | $224,781 |
| % Growth | -0% | 16.4% | -9.8% | – |
| Gross Profit | $137,439 | $137,193 | $118,967 | $133,030 |
| % Margin | 58.2% | 58.1% | 58.7% | 59.2% |
| EBITDA | $54,792 | $44,675 | $34,535 | $44,186 |
| % Margin | 23.2% | 18.9% | 17% | 19.7% |
| Net Income | $25,789 | $21,246 | $12,158 | $18,206 |
| % Margin | 10.9% | 9% | 6% | 8.1% |
| EPS Diluted | 0.061 | 0.05 | 0.028 | 0.044 |
| % Growth | 21.2% | 78.6% | -36.4% | – |
| Operating Cash Flow | $46,427 | $22,199 | $13,811 | $41,954 |
| Capital Expenditures | -$4,948 | -$10,224 | -$6,172 | -$8,003 |
| Free Cash Flow | $41,479 | $11,975 | $7,639 | $33,951 |